"When will life get back to 'normal'?" When Advisory Board's Brandi Greenberg explored that question last month, she identified "good," "bad," and "ugly" scenarios—and offered probabilities for each one. Now, after a month in which coronavirus infections have plummeted but frightening new variants have emerged, she’s back to update her estimates.
Coronavirus testing has declined sharply in the United States since January, alarming many public health experts, who say testing remains critical in America's fight against the coronavirus. But other experts argue that testing was never effectively used to contain the epidemic in the first place.
The United States is now running well ahead of the pace required to meet President Biden's goal of administering 100 million Covid-19 vaccine doses within his first 100 days in office—although some experts had criticized that goal as too modest.
The Senate Finance Committee on Wednesday voted 14-14 on whether to advance California Attorney General Xavier Becerra's nomination for HHS secretary, which means Senate Majority Leader Charles Schumer (D-N.Y.) can now bring the nomination to the full Senate for a vote, in today's bite-sized hospital and health industry news from the District of Columbia, Massachusetts, Michigan, and Oklahoma.